Levoketoconazole and Olaparib: Interaction Details

Brand names
Olaparib
Lynparza
Levoketoconazole
Recorlev
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

What Happens When You Take Levoketoconazole With Olaparib

What can happen when they are taken together (rated Contraindicated)

Increased exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Levoketoconazole must not be given together with sensitive CYP3A4 substrates, as this combination is . Because levoketoconazole inhibits CYP3A4, using it alongside a sensitive CYP3A4 substrate can raise the substrate's exposure, which may in turn heighten the risk of adverse reactions associated with that substrate. A drug interaction study evaluated levoketoconazole 400 mg once daily given with felodipine, a sensitive CYP3A4 substrate, and found that felodipine rose by 1007% and rose by 937%.1

The Levoketoconazole and Olaparib Interaction, Explained

Levoketoconazole can raise olaparib levels in your body. Olaparib (Lynparza) is a cancer medicine that your body breaks down mostly with an enzyme called . Levoketoconazole (Recorlev), used for high cortisol in Cushing's syndrome, blocks that enzyme. With the enzyme slowed, more olaparib can stay in your blood, which may mean more side effects such as nausea, tiredness, anemia, or low blood counts.

Our records list this combination as , so it is normally avoided. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review your options and decide on the safest plan for you.

Mechanism: Levoketoconazole is a strong . Olaparib is a CYP3A4 (the major pathway of its ), so is expected to increase olaparib exposure (, ) and the risk of dose-related adverse effects ( including anemia, nausea, fatigue). Olaparib is not a , so reduced means higher active drug.

  • Magnitude: Not studied with olaparib specifically. The labeling cites felodipine (sensitive CYP3A4 substrate) AUC and Cmax rising by about 1007% and 937%.
  • Severity/evidence: ; evidence rated probable; onset unspecified.
  • Management: Avoid per labeling. If the combination is considered unavoidable, individualize therapy with the care team and monitor closely (e.g., blood counts, tolerability). Consider alternatives.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Levoketoconazole and Olaparib Interact

The likely mechanism

of -substrate by levoketoconazole

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Levoketoconazole and Olaparib Interaction

The documented advice is that this combination is , so care teams generally look for a different approach rather than using both together.

  • Keep taking your medicines as prescribed until your prescriber or pharmacist tells you otherwise.
  • Make sure both your oncology team and the prescriber of levoketoconazole know you take both drugs.
  • Ask whether an alternative is appropriate for you. If your team decides both are needed, the dose may need to be adjusted and individualized, and your team may monitor you more closely.
  • Report new or worsening nausea, unusual tiredness, paleness, or signs of infection or bruising to your care team.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Levoketoconazole or Olaparib need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: RECORLEV oral tablets, levoketoconazole oral tablets

    In a drug interaction study (N=14), levoketoconazole 400 mg once daily given together with felodipine (a sensitive ) raised felodipine by 1007% and by 937%, relative to felodipine given alone.1

Levoketoconazole and Olaparib: Common Questions

How serious is the Levoketoconazole and Olaparib interaction?

It is rated . These should generally not be used together.

How is the Levoketoconazole and Olaparib interaction managed?

The documented advice is that this combination is , so care teams generally look for a different approach rather than using both together. Keep taking your medicines as prescribed until your prescriber or pharmacist tells you otherwise. Make sure both your oncology team and the prescriber of levoketoconazole know you take both drugs. Ask whether an alternative is appropriate for you… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Levoketoconazole and Olaparib Interaction

Ask in your own words about taking Levoketoconazole and Olaparib together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: RECORLEV(R) oral tablets, levoketoconazole oral tablets. Xeris Pharmaceuticals Inc (per FDA), Chicago, IL, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Levoketoconazole and Olaparib

Also serious with Olaparib

Also serious with Levoketoconazole

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Olaparib

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together. This interaction.
  • Major Potentially serious — often needs a change or close monitoring.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.